Dx&Vx (DXVX) Partners with Over 40 Global Companies at BIO USA, "Focused Discussions on Overseas Out-Licensing Deals"
Oral obesity drug with world-first mechanism of action unveiled, drawing strong on-site interest Following successful Phase 1 clinical results, global discussions on OVM-200 expand Meetings with over 40 companies, including major pharmaceutical...
TIER IV joins imec's Automotive Chiplet Program to accelerate chiplet-based architectures and AI accelerators for SDVs
TOKYO, March 10, 2026 /PRNewswire/ -- TIER IV, the pioneering force behind open-source software for autonomous driving, has officially joined the Automotive Chiplet Program (ACP) overseen by imec, a world-leading research and innovation center in...